Clinical Trials
83 trialsAnti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Ohio State University Comprehensive Cancer Center
MET-MRI
Technical University of Munich
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
St. Jude Children's Research Hospital
STEMRI
Institut Claudius Regaud
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mayo Clinic
ERAS801-SARG
Jonsson Comprehensive Cancer Center
Oral Gallium Maltolate for Recurrent Glioblastoma
Medical College of Wisconsin
AB-218-IIT-201
Melbourne Health
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
M.D. Anderson Cancer Center
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
SLITT-GBM
King's College Hospital NHS Trust
Surgical Nivolumab And Ipilimumab For Recurrent GBM
Dana-Farber Cancer Institute
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Northwestern University
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
A Study of Abemaciclib in Recurrent Glioblastoma
Dana-Farber Cancer Institute
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
National Institutes of Health Clinical Center (CC)
VB-111 in Surgically Accessible Recurrent/Progressive GBM
Dana-Farber Cancer Institute
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Thomas Jefferson University
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
Glioma Microenvironment an Exploratory Study
Hospital Sirio-Libanes
Tumor Vaccines for Solid Tumors
Huashan Hospital
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
Washington University School of Medicine
Determination of Immune Phenotype in Glioblastoma Patients
University of Ulm
In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI
Stanford University
CLTBME
Sun Yat-sen University
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
Northwestern University
CSA
Assistance Publique - Hôpitaux de Paris
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Children's Oncology Group
The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of Glioma
Huashan Hospital
Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data
Huashan Hospital
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
Radiation Therapy Following Surgery to Remove Brain Metastases
Jonsson Comprehensive Cancer Center
Sirolimus in Treating Patients With Glioblastoma Multiforme
Jonsson Comprehensive Cancer Center
OPTMETACER
University Hospital, Caen
DEND/TIA
Clinica Universidad de Navarra, Universidad de Navarra
PARADIGMA
McGill University Health Centre/Research Institute of the McGill University Health Centre
Re-craniotomy and Complications After Elective Neurosurgery
Chiang Mai University
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
Dana-Farber Cancer Institute
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Ohio State University Comprehensive Cancer Center
Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Ohio State University Comprehensive Cancer Center
TOUCH
First Affiliated Hospital of Fujian Medical University
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Dana-Farber Cancer Institute
OCS
Kasr El Aini Hospital
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
GBM-Vax
Activartis Biotech
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC